CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells

European Journal of Cancer

Volumn 48, Issue 10, 2012, Pages 1558-1569

  Reinartz, Silke ^a   Failer, Sophie ^a   Schuell, Tina ^a   Wagner, Uwe ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Apoptosis; Cancer; Cell growth; Gene silencing; Invasion; MUC16

Indexed keywords

GELATINASE A; MUCIN; MUCIN 16; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER INVASION; CARCINOGENESIS; CELL ADHESION; CELL CYCLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T CELL LYMPHOMA; TUMOR GROWTH;

APOPTOSIS; BREAST NEOPLASMS; CA-125 ANTIGEN; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITOPES; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; TRANSFECTION;

EID: 84862003540     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2011.07.004     Document Type: Article

References (37)

1. R.C. Bast Jr., F.J. Xu, and Y.H. Yu CA 125: the past and the future Int J Biol Markers 13 1998 179 187
2. T.J. O'Brien, J.B. Beard, and L.J. Underwood The CA125 gene: an extracellular superstructure dominated by repeat sequences Tumor Biol 22 2001 348 366
3. B.W. Yin, and K.O. Lloyd Molecular cloning of the ca125 ovarian cancer antigen. Identification as a new mucin, muc16 J Biol Chem 276 2001 27371 27375
4. B.W. Yin, A. Dnistrian, and K.O. Lloyd Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene Int J Cancer 98 2002 737 740
5. T.J. O'Brien, J.B. Beard, and L.J. Underwood The CA 125 gene: a newly discovered extension of the glycosylated N-terminal domain doubles the size of this extracellular superstructure Tumour Biol 23 2002 154 169
6. N.K. Wong, R.L. Easton, and M. Panico Characterization of the oligosaccharides associated with the human ovarian tumor marker CA125 J Biol Chem 278 2003 28619 28634
7. M.J. Duffy, J.M. Bonfrer, and J. Kulpa CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use Int J Gynecol Cancer 15 2005 679 691
8. A. Rump, Y. Morikawa, and M. Tanaka Binding of ovarian cancer antigen CA125/MUC16 to mesothelin mediates cell adhesion J Biol Chem 279 2004 9190 9198
9. N. Scholler, B. Garvik, and M. Hayden-Ledbetter Development of a CA125-mesothelin cell adhesion assay as a screening tool for biologics discovery Cancer Lett 247 2007 130 136
10. J.A. Gubbels, J.A. Belisle, and M. Onda Mesothelin-MUC16 binding is a high affinity, N-glycan dependent interaction that facilitates peritoneal metastasis of ovarian tumors Mol Cancer 5 2006 50 64
11. M. Comamala, M. Pinard, and C. Thériault Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signaling in NIH:OVCAR3 ovarian carcinoma cells Br J Cancer 104 2011 989 999
12. M. Boivin, D. Lane, and A. Piché CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis Gynecol Oncol 115 2009 407 413
13. M.S. Patankar, Y. Jing, and J.C. Morrison Potent suppression of natural killer cell response mediates by the ovarian tumor marker CA125 Gynecol Oncol 99 2005 704 713
14. J.A. Gubbels, M. Felder, and S. Horibata MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells Mol Cancer 9 2010 11 25
15. J.A. Belisle, J.A. Gubbels, and V.A. Raphael Peritoneal natural killer cells from epithelial ovarian cancer patients show an altered phenotype and bind to the tumour marker MUC16 (CA125) Immunology 122 2007 418 429
16. J.A. Belisle, S. Horibata, and J.A. Gubbels Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes Mol Cancer 9 2010 118 131
17. Toth M, Fridman R. Assessment of gelatinases (MMP-2 and MMP-9) by gelatine zymography. In: Brooks SA, Schumacher U, editors. Methods in molecular medicine. Vol. 57: metastasis research protocols, vol. 1: analysis of cells and tissues. Totowa, New York: Human Press Inc.; 2008. p. 163-74.
18. T. Dharma Rao, K.J. Park, and P. Smith-Jones Novel monoclonal antibodies against the proximal (carboxy-terminal) portions of MUC16 Appl Immunohistochem Mol Morphol 18 2010 462 472
19. E. Hangen, K. Blomgren, and P. Bénit Life with or without AIF Trends Biochem Sci 35 2010 278 287
20. S.P. Cregan, A. Fortin, and J.G. Maclaurin Apoptosis-inducing factor is involved in the regulation of caspase independent neuronal cell death J Cell Biol 158 2002 507 517
21. X. Yang, M. Fraser, and M.R. Abedini Regulation of apoptosis-inducing factor-mediated, cisplatin-induced apoptosis by Akt Br J Cancer 98 2008 803 808
22. B.C. Barnhart, J.C. Lam, and R.M. Young Effects of 4E-BP1 expression on hypoxic cell cycle inhibition and tumor cell proliferation and survival Cancer Biol Ther 7 2008 1441 1449
23. G. Armengol, F. Rojo, and J. Castellví 4E-binding protein 1: a key molecular "tunnel factor" in human cancer with clinical implications Cancer Res 67 2007 7551 7555
24. C. Thériault, M. Pinard, and M. Comamala MUC16 (CA126) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis Gynecol Oncol 2011 [Epub ahead of print]
25. S. Bafna, S. Kaur, and S.K. Batra Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells Oncogene 29 2010 2893 2904
26. I.K. Gipson, T. Blalock, and A. Tisdale MUC16 is lost from the uterodome (pinopode) surface of the receptive human endometrium: in vitro evidence that MUC16 is a barrier to trophoblast adherence Biol Reprod 78 2008 134 142
27. T.D. Blalock, S.J. Spurr-Michaud, and A.S. Tisdale Functions of MUC16 in corneal epithelial cells Invest Ophthalmol Vis Sci 48 2007 4509 4518
28. H. Naora, and D.J. Montell Ovarian cancer metastasis: integrating insights from disparate model organisms Nat Rev Cancer 5 2005 355 366
29. M.V. Barbolina, B.P. Adley, and D.L. Kelly Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion Int J Cancer 125 2009 816 825
30. M.V. Barbolina, B.P. Adley, and E.V. Ariztia Microenvironmental regulation of membrane type I matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression J Biol Chem 282 2007 4924 4931
31. S.M. Ellerbroek, D.A. Fishman, and A.S. Kearns Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin Cancer Res 59 1999 1635 1641
32. S.M. Ellerbroek, Y.I. Wu, and C.M. Overall Functional interplay between type I collagen and surface matrix metalloproteinase activity J Biol Chem 276 2001 24833 24842
33. K. Shield, C. Riley, and M.A. Quinn Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis J Carcinog 6 2007 11
34. K.L. Sodek, M.J. Ringuette, and T.J. Brown MT1-MMP is the critical determinant of matrix degradation and invasion by ovarian cancer cells Br J Cancer 97 2007 358 367
35. H.A. Kenny, and E. Lengyel MMP-2 functions as an early response protein in ovarian cancer metastasis Cell Cycle 8 2009 683 688
36. N.M. Moss, M.V. Barbolina, and Y. Liu Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloprotease: a potential role in i.p. metastatic dissemination Cancer Res 69 2009 7121 7129
37. Y. Wu, X. Guo, and Y. Brandt Three-dimensional collagen represses cyclin E1 via beta1 integrin in invasive breast cancer cells Breast Cancer Res Treat 2010 [Epub ahead of print]